Collegium

Egalet

This pharmaceutical company develops and commercialises abuse-deterrent oral medicines to treat acute and chronic pain for patients and healthcare providers.

Depomed

This pharmaceutical company develops and markets branded prescription medicines for patients with neurology, oncology, and inflammatory conditions.

Harmony Biosciences

This pharmaceutical company develops and commercialises therapies for patients living with rare neurological diseases, such as narcolepsy and other sleep-wake disorders.

Latigo

This clinical-stage biopharmaceutical company develops non-opioid medicines to treat acute and chronic pain for patients needing alternatives to addictive painkillers.

Mimetic Medicines

This company develops non-opioid peptide drug candidates for patients suffering from chronic pain.

Orexo AB

This pharmaceutical company develops improved medications and digital therapies for patients with opioid use disorder, cancer pain and insomnia.

Eton Pharmaceuticals

This company develops and commercialises prescription medicines to treat patients living with rare diseases.

Centrexion Therapeutics

This biopharmaceutical company develops non-opioid and non-addictive therapies for patients with chronic pain conditions like osteoarthritis and diabetic neuropathy.